Targeting of lipid ...
 
Notifications
Clear all

Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells

2 Posts
2 Users
2 Likes
708 Views
johan
(@j)
Joined: 4 years ago
Posts: 1190
Topic starter  

"The combined treatment of low toxic AMPK activators, the transforming growth factor beta-activated kinase 1 (TAK1) and fatty acid synthase (FASN) inhibitors synergistically impair oncogenic augmentation of ovarian cancer. Collectively, targeting lipid metabolism signaling axis impede ovarian cancer peritoneal metastases." Rain R. Chen, Mingo M. H. Yung, Yang Xuan, Shijie Zhan, Leanne L. Leung, Rachel R. Liang, Thomas H. Y. Leung, Huijuan Yang, Dakang Xu, Rakesh Sharma, Karen K. L. Chan, Siew-Fei Ngu, Hextan Y. S. Ngan & David W. Chan


   
Daniel and Daniel reacted
Quote
Daniel
(@daniel)
Admin
Joined: 7 years ago
Posts: 1156
 

Thank you Johan!


   
ReplyQuote
Share: